Does hydroxycarbamide therapy really induce leukemic transformation in patients with essential thrombocythemia?

Leuk Res. 2019 Jan:76:94-95. doi: 10.1016/j.leukres.2018.11.011. Epub 2018 Nov 22.

Authors

B Marcellino¹, R Hoffman¹, J Mascarenhas²

Affiliations

¹ Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United States.
² Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United States. Electronic address: [email protected].

PMID: 30501902
DOI: 10.1016/j.leukres.2018.11.011

No abstract available

Publication types

Editorial
Letter

MeSH terms

Cell Transformation, Neoplastic / chemically induced*
Disease Progression
Humans
Hydroxyurea / adverse effects*
Hydroxyurea / therapeutic use
Thrombocythemia, Essential / drug therapy
Thrombocythemia, Essential / pathology*

Substances

Hydroxyurea